Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Building bioorthogonal click-release capable artificial receptors on cancer cell surface for imaging, drug targeting and delivery

Acta Pharmaceutica Sinica B(2022)10.1016/j.apsb.2022.12.018Source: DataRank Database

Building bioorthogonal click-release capable artificial receptors on cancer cell surface for imaging, drug targeting and delivery is a research paper published in Acta Pharmaceutica Sinica B (2022). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.97)OA: goldTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Peng Ji ORCID,Giri Gnawali,Mengyang Chang ORCID,Feng Gao ORCID,Hang Xu ORCID

Live enrichment

PubMed:37425049 PMC:PMC10326247 OpenAlex:https://openalex.org/W4313420891

National Institutes of Health

Grant: 5R01GM130772

NIGMS NIH HHS

Grant: R01 GM130772

National Institutes of Health

Grant: 5R01GM130772-04

Design of Fe2+ and H2O2 Induced Proximity Functionalized Imaging Probes for the Control of Cellular Functions

FWCI

1.97

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.apsb.2022.12.018

publisherhttps://doi.org/10.1016/j.apsb.2022.12.018

publisherhttps://api.elsevier.com/content/article/PII:S2211383522005275?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211383522005275?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37425049

Fields of Study

Click Chemistry and ApplicationsProtein Degradation and InhibitorsMonoclonal and Polyclonal Antibodies Research0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Bioorthogonal chemistryProdrugBioconjugationCancer cellDrug deliveryChemistryTetrazineReceptorClick chemistryTargeted drug deliveryCellCancerCancer researchNanotechnologyBiochemistryMaterials scienceBiologyCombinatorial chemistryMedicineInternal medicineProtein degradationArtificial ReceptorClick And ReleaseLocal ActivationOriginal ArticleTherapeutics. PharmacologyRM1-950

Sustainable Development Goals

SDG 0: Good health and well-being